Dutch hematologists examined results of 26 years of low-dose immune tolerance induction (ITI) therapy as a treatment regimen for inhibitory alloantibodies against factor VIII in patients with severe hemophilia A.
A new study showed that giving just one-fifth the usual dose of the polio vaccine may protect babies against the virus nearly as well as a full dose, as long as it is injected just beneath the skin, according to a recent study.
A recent trial demonstrated equal clinical efficacy between a freeze-dried and a liquid IVIG preparation for maintenance treatment of CIDP.
This new bill would allow plan sponsors to pay for off-label drug uses on a case-by-case basis and review the safety and efficacy of drugs.
A first-of-its-kind prostate cancer treatment that uses the body’s immune system to fight the disease has been approved by the U.S. Food and Drug Administration.
According to the Centers for Disease Control and Prevention, the rotavirus vaccine is now contraindicated for infants diagnosed with severe combined immunodeficiency.
Octapharma USA has initiated a voluntary withdrawal of all lots of Octagam (immune globulin intravenous [human] 5% liquid preparation) from the U.S. marketplace.
The Centers for Disease Control and Prevention has issued a comprehensive update on seasonal flu vaccination, which includes the new universal recommendation for everyone except infants younger than 6 months old.
A recent study shows measles-mumps-rubella-varicella (MMRV) vaccination is associated with an increased risk of fever and seizure in young children, above that already associated with measles-containing vaccines.
Updates on recent FDA approvals, appointments, acquisitions and alliances in the pharmaceutical industry.
The U.S. Food and Drug Administration has launched two new websites relating to drug safety.
U.S. investigators are determining if there is evidence to support the efficacy of IVIG therapy specifically in autoimmune mucocutaneous blistering diseases (AMBDs).